Grand Challenges — Cost-Reducing Innovations for Ready-to-Use Therapeutic Food
Funds global teams developing innovations in protein, lipids, packaging, and manufacturing that reduce the ex-factory unit cost of ready-to-use therapeutic food by at least 30%.
This grant is administered by the Bill & Melinda Gates Foundation under its Grand Challenges program. It funds innovations in food science, materials science, and manufacturing technology that can achieve a 30% or greater reduction in the ex-factory unit cost of ready-to-use therapeutic food (RUTF) — the primary treatment for severe acute malnutrition in children. The program is distinct from the …
Food science and manufacturing innovations to reduce RUTF ex-factory unit cost by at least 30% in Sub-Saharan Africa and South Asia. Approaches include: protein source diversification (e.g., locally available legumes, insects, single-cell proteins), lipid optimization (reducing expensive nut-based fats), packaging materials science (reducing multi-layer sachet cost), production technology (lower-capex manufacturing systems, co-production), and supply chain innovation (local procurement, decentralized production). Option A covers early-stage innovation validation; Option B covers advanced scale and implementation.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up